Expansion & Reach BIOSerenity works with more than 200 hospitals across Europe and processes over 100,000 patient diagnoses per year, indicating a strong regional market presence and a scalable hospital-based sales opportunity to expand partnerships and upsell across institutions.

Integrated Solutions Their platform combines physiological sensors, an IoT backbone, apps, and AI to detect digital biomarkers, suggesting cross-sell potential of expanded analytics, patient monitoring bundles, and value-added services to existing hospital networks.

Neurology Focus A strong emphasis on neurology, sleep disorders, and cardiology opens targeted selling angles for neurology departments, sleep clinics, and cardiology units seeking digital biomarkers and remote monitoring capabilities.

Financial Strength With $120M in funding and annual revenue in the mid-range of tens of millions, BIOSerenity demonstrates capital backing and market traction, enabling larger contract opportunities, multi-year deals, and joint go-to-market initiatives.

Industry Presence Active participation in major medical events (e.g., AAN 2026) and a Paris-based HQ position BIOSerenity well for prestige-driven procurement cycles, partnerships with leading hospitals, and regional marketing campaigns to accelerate enterprise sales.